Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator

The summary for the Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Assistant Secretary for Preparedness and Response, which is the U.S. government agency offering this grant.
Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator: The current pipeline of candidate antimicrobial products is insufficient to counter the threat of antimicrobial resistance . A novel collaborative model is needed to spur innovation and investment towards new antimicrobial products to repopulate the early development pipeline. In 2014, the United States Government released the National Strategy for Combating Antimicrobial Resistant Bacteria. A component of the National Strategy is to establish a Biopharmaceutical Accelerator for Combating Antibiotic-Resistant Bacteria [Accelerator] to fund Research and Development (R&D) activities to help progress candidate products from the proof-of-concept stage through pre-clinical development. Candidates that graduate from the Accelerator will be better positioned for R&D investment and clinical development. There are various Accelerator models in the marketplace. The Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID) Accelerator will be a non-equity accelerator that provides non-dilutive funding to product developers for R&D activities and enables the product developers to retain full ownership and control of their company. The Accelerator for CARB will be focusing only on antibacterial products.
BARDA will provide direct funding and NIAID will provide in-kind services (e.g. preclinical services, technical expertise) to the Accelerator [the cooperative agreement recipient] that will manage a portfolio of investments of early stage antimicrobial product candidates.
Federal Grant Title: Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator
Federal Agency Name: Assistant Secretary for Preparedness and Response
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: EP-PMC-16-001
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.360
CFDA Descriptions: Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development
Current Application Deadline: Apr 15, 2016 Applications must be submitted elect
Original Application Deadline: Apr 15, 2016 Applications must be submitted elect
Posted Date: Feb 17, 2016
Creation Date: Feb 17, 2016
Archive Date: May 15, 2016
Total Program Funding: $250,000,000
Maximum Federal Grant Award: $30,000,000
Minimum Federal Grant Award: $30,000,000
Expected Number of Awards: 2
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Private institutions of higher education
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Research institutions and Non-domestic (non-U.S.) entities are eligible.
Link to Full Grant Announcement
Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator
Grant Announcement Contact
Grants.gov Contact Center Phone Number: 1-800-518-4726 Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays. support@grants.gov
Grants.gov Customer Support

Assistant Secretary for Preparedness and Response 202-245-0961
Similar Government Grants
2019 BARDA Division of Research, Innovation and Ventures (BARDA DRIVe) Accelerator Network...
QUICKFIRE
BARDA Division of Research, Innovation and Ventures (DRIVe) Accelerator Network
Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Anno...
Broad Agency Announcement (BAA) for Advanced Research and Development to Expedite the Iden...
Opportunity EP-IDS-10-002
Opportunity EP-IDS-10-003
Development of Sustainable Influenza Vaccine Production Capacity in Under Resourced Nation...
More Grants from the Assistant Secretary for Preparedness and Response
Pediatric Disaster Care Centers of Excellence
2019 BARDA Division of Research, Innovation and Ventures (BARDA DRIVe) Accelerator Network...
Hospital Preparedness Program Cooperative Agreement
QUICKFIRE
Aspr Funding For Healthcare And Public Health (hph) Sector Information Sharing And Analysi...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020 FederalGrants.com